Quintrio
Home

SPECIAL INDUSTRY MACHINERY, NEC

Trio-Tech International Common Stock

TRT

Trio-Tech International is a provider of reliability test equipment and services to the semiconductor and other industries. Its customers are from the automotive electronics, industrial electronics, computing and data storage, consumer electronics, and communication markets. The company operates its business in two segments: Semiconductor Back-end Solutions and Industrial Electronics. Geographically, the Company operates in the United States (U.S.), Singapore, Malaysia, Thailand, and China.

Last trade $4.61
Day change -$0.345 (-6.97%)
Day range $4.49 – $4.98
Volume 94,982
Market cap $51M

Open XNAS

Fundamentals

Key company ratios and reported financial statements.

Source: Massive.com

Key ratios

Valuation

Market capitalization
$51.09M
Price / earnings
69.51×
Price / book
1.1×
Price / sales
0.76×
EV / sales
0.5×
EV / EBITDA
9.02×

Profitability

Earnings per share
$0.07
Return on assets
1.08%
Return on equity
1.59%
Dividend yield
0%

Liquidity and leverage

Debt / equity
0.02×
Current ratio
2.73×
Quick ratio
2.37×
Cash ratio
0.96×

Cash flow

Price / cash flow
—
Price / free cash flow
—
Free cash flow
-$3.35M

Ratios use trailing-twelve-month financials and market data as of Nov 16, 2026.

Financial statements

Income and cash flow amounts are for the period; balance sheets are point-in-time snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are displayed when available.

Income statement for TRT, quarterly periods
Line itemQ1 FY2027 Sep 30, 2026Q4 FY2026 Jun 30, 2026Q3 FY2026 Mar 31, 2026Q2 FY2026 Dec 31, 2025Q1 FY2026 Sep 30, 2025Q4 FY2025 Jun 30, 2025Q3 FY2025 Mar 31, 2025Q2 FY2025 Dec 31, 2024
Revenue$19.95M$14.93M$16.51M$15.65M$15.51M$10.67M$7.38M$8.62M
Cost of revenue$15.83M$12.15M$13.96M$13.15M$12.93M$8.04M$5.41M$6.4M
Gross profit$4.12M$2.78M$2.55M$2.5M$2.59M$2.63M$1.98M$2.22M
Selling, general and administrative$2.76M$2.95M$2.54M$2.3M$2.45M$2.07M$2.28M$2.14M
Research and development$98K$98K$99K$106K$94K$92K$90K$114K
Total operating expenses$2.86M$3.05M$2.64M$2.4M$2.54M$2.16M$2.37M$2.26M
Operating income$1.26M-$266K-$81K$97K$46K$466K-$397K-$37K
Interest expense-$9K-$24K-$11K-$22K-$8K-$9K-$10K-$13K
Income before taxes$1.2M-$257K$107K$312K$227K$152K-$475K$675K
Income taxes$350K-$59K$146K$77K$64K-$28K$6K$139K
Net income$846K-$200K-$37K$291K$165K$170K-$476K$529K
Net income attributable to common shareholders$846K-$199K-$38K$126K$77K$183K-$495K$507K
EBITDA$2.2M$414K$557K$538K$578K$1.11M$274K$674K
Basic earnings per share$0.08-$0.02$0.00$0.01$0.01$0.02-$0.06$0.06
Diluted earnings per share$0.07-$0.02$0.00$0.01$0.01$0.02-$0.06$0.06

Recent news

Company coverage with links to the original publishers.

Publication times in UTC
Zacks Investment Research

Trio-Tech Upgraded to Outperform on Backlog Growth & Strong Liquidity

Trio-Tech International (TRT) was upgraded to 'Outperform' from 'Neutral' due to growing backlog of $24.2 million, expansion into automotive semiconductor applications, and improved financial position with $28.5 million in cash and $3.4 million in operating cash flow. The company is diversifying beyond AI into automotive and aerospace markets while its Industrial Electronics business shows early recovery signs. However, margin pressures and execution risks remain concerns.

Zacks Investment Research

Trio-Tech Plunges More Than 64% in 6 Months: How to Play the Stock?

Trio-Tech International (TRT) shares have declined 64.1% over six months, significantly underperforming the industry despite strong business fundamentals. The company secured new contracts for AI and automotive semiconductor testing, expanded Malaysian capacity, and improved its financial position. However, margin pressure from lower-margin testing services, elevated operating expenses, and customer concentration risks have constrained profitability. While the stock trades at a discount to industry peers, analysts recommend caution until profitability improves and earnings visibility strengthens.

Zacks Investment Research

Trio-Tech Stock Plunges Post Q4 Earnings Despite Strong Revenue Growth

Trio-Tech International (TRT) stock fell 43.9% following Q4 fiscal 2026 earnings despite strong 39.9% revenue growth to $14.9 million. While Semiconductor Back-end Solutions revenues surged 84.7%, the company posted a net loss of $199,000 and gross margins contracted significantly to 16.6% from 25.1%. The stock decline reflects investor concerns over profitability despite robust top-line growth driven by AI and automotive semiconductor testing demand.

Zacks Investment Research

TRT vs. ASYS: Which Semiconductor Equipment Stock Is the Better Buy?

Trio-Tech International (TRT) and Amtech Systems (ASYS) are two semiconductor equipment suppliers with different focuses. TRT specializes in testing and reliability solutions for AI and automotive applications, while ASYS focuses on advanced packaging and fabrication equipment. Despite both stocks trading above historical valuations, ASYS is recommended as the better buy due to its stronger operational leverage, improving margins, debt-free balance sheet, and less demanding valuation expectations compared to TRT.

Benzinga

Why Hempacco Are Trading Lower By 58%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Gainers SeqLL Inc. (NASDAQ: SQL) shares jumped 120% to $1.85 after dropping around 39% on Thursday. SeqLL recently announced the establishment of a two-year Cooperative Research and Development Agreement with the U.S. Department of Justice's Federal Bureau of Investigation. Hillstream BioPharma, Inc. (NASDAQ: HILS) rose 92.3% to $2.27 after the company reported initial results evaluating the synergy of HSB-1216 with immune checkpoint inhibitors in KRAS G12C-mutated non-small cell lung cancer cells, Calu-1, with Pembrolizumab, demonstrating significantly greater tumor inhibition. Vallon Pharmaceuticals, Inc. (NASDAQ: VLON) surged 71.2% to $0.4588. Lixte Biotechnology Holdings, Inc. (NASDAQ: LIXT) gained 36.6% to $1.49. LIXTE Biotechnology recently noted that a team of scientists reported that in three difficult-to-treat cancer types, LIXTE's lead compound, LB-100, combined with an inhibitor of the WEE1 kinase, causes unexpectedly effective cancer cell killing. Expion360 Inc. (NASDAQ: XPON) gained 26.4% to $2.51 after the company announced it has been selected by Cube Series as the exclusive supplier of lithium-ion batteries for a ultra-lightweight foldable campler. Nova LifeStyle, Inc. (NASDAQ: NVFY) jumped 26% to $1.31. VistaGen Therapeutics, Inc. (NASDAQ: VTGN) climbed 23% to $0.1741 after dropping around 24% on Thursday. VistaGen Therapeutics recently reported a Q3 FY23 net loss of $(9.8) million or $(0.05) per share. Proto Labs, Inc. (NASDAQ: PRLB) gained 22.4% to $37.24 as the company reported a fourth-quarter revenue decline of 6.5% year-over-year to $115.6 million, beating the consensus of $109.8 million. EZFill Holdings Inc. (NASDAQ: EZFL) rose 22.4% to $0.4897. EzFill announced preliminary unaudited 2022 Q4 revenues of $4.9 million, up 143% year over year. Akanda Corp. (NASDAQ: AKAN) jumped 21.7% to $0.2220. Oscar Health, Inc. (NYSE: OSCR) gained 19.2% to $4.53 following upbeat Q4 earnings. Lions Gate Entertainment Corp. (NYSE: LGF-A) shares climbed 18.8% to $9.80 following Q3 results. Bon Natural Life Limited (NASDAQ: BON) gained 16.3% to $1.43 after reporting a rise in FY earnings. Brera Holdings PLC (NASDAQ: BREA) rose 14.7% to ...

Dividends

Declared distributions and recorded event dates. Forecasts are not shown.

Updated daily

No declared upcoming dividend found.

Ex-dividendAmount / sharePay dateType
Feb 21, 2008$0.055Mar 25, 2008unknown
Dec 13, 2006$0.05Jan 15, 2007special
Jan 6, 2006$0.25Jan 25, 2006special

Stock splits

Historical share-structure events and their execution dates.

Updated daily
Execution dateSplit ratioEvent type
Jan 5, 20262-for-1forward split